Introducing Resomer LG 855 S, a remarkable polymer designed to meet the needs of biomedical applications. This biodegradable, biocompatible, and bioresorbable copolymer is composed of L-Lactide and Glycolide, making it an extraordinary choice for a wide range of medical purposes.
Resomer LG 855 S is an ester-terminated copolymer composed of L-Lactide (C3H4O2) and Glycolide (C2H2O2), with a ratio of lactide to glycolide of approximately 85:15. The chemical formula of this polymer is HO[C3H4O2] [C2H2O2]mCH3.
L-Lactide is a cyclic diester derived from lactic acid. It is a monomer used in the production of poly(lactic acid) (PLA) polymers. L-Lactide contributes to the excellent biodegradability and biocompatibility properties of Resomer LG 855 S.
Glycolide is a cyclic diester derived from glycolic acid. It is an important monomer in the synthesis of poly(glycolic acid) (PGA) polymers. Glycolide enhances the mechanical properties and degradation kinetics of Resomer LG 855 S, making it suitable for various medical applications.
Resomer LG 855 S offers a plethora of applications within the biomedical field, thanks to its outstanding characteristics. Some of its potential uses include:
Resomer LG 855 S complies with the highest quality and safety standards in the industry, ensuring its suitability for use in biomedical applications. It meets the following regulatory requirements:
These certifications guarantee the reliability and biocompatibility of Resomer LG 855 S, making it a trusted and preferred choice for medical professionals.
Resomer LG 855 S is the ideal solution for biomedical applications that require a biodegradable, biocompatible, and bioresorbable copolymer. Offering exceptional control over drug delivery, tissue engineering capabilities, and a range of other advantages, this copolymer is revolutionizing the field of medical materials. With its regulatory compliance and outstanding composition, Resomer LG 855 S is a reliable choice for medical professionals seeking advanced biomaterials for their applications.